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Abstract 
Background: Unconjugated bilirubin (UCB) plays a protective role in coronary artery disease. Red cell distribution 
width (RDW), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are inflammatory biomark-
ers and higher levels are related to atherosclerosis and adverse cardiovascular events.
Aim: We aimed to investigate the relation between UCB levels and RDW, NLR, PLR in people with Gilbert’s syndrome 
(GS).
Materials and methods: We selected 2166 subjects (1082 with GS and 1084 healthy controls) from a database 
having 33,695 people. RDW, NLR and PLR were investigated in the subjects with GS and compared with the healthy 
controls. Linear regression analysis was used to evaluate the relation between variables.
Results: NLR and PLR were higher in the subjects with GS compared to the controls (p < 0.001). RDW was similar in 
both groups (p = 0.318). UCB was negatively correlated with lymphocyte counts (p = 0.040), and positively correlated 
with RDW (p < 0.001) and PLR (p = 0.037) in the subjects with GS. There was no significant correlation between UCB 
and NLR (p = 0.078). RDW (p < 0.001) and lymphocyte counts (p = 0.030) were significantly associated with UCB 
levels in the regression analysis conducted in the subjects with GS.
Conclusion: There is a negative association between UCB and NLR, PLR due to low amounts of lymphocyte counts, 
which causes increased risk of CVD. These results suggest that the cardio-protective effect of UCB is due to both anti-
oxidative and anti-inflammatory ways indirectly.
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Background
Gilbert’s syndrome is an inborn disorder of bilirubin glucu-
ronidation, characterized by recurrent episodes of jaundice 
and may be triggered by some conditions such as; dehy-
dration, fasting, menstruation, heavy exercise and other 
accompanying diseases. As a result of this disorder, serum 
UCB is above than normal levels (Sieg et  al. 1987). The 
prevalence of GS has been reported to be between 3 and 10 
percent in different populations (Kundur et al. 2015). UCB 
plays a protective role in diseases related with oxidative 
stress as an antioxidant in low concentrations (20–100 μM) 
(between 1.17 and 5.85  mg/dL) (Schwertner and Vítek 
2008). It has been shown that unconjugated hyperbiliru-
binemia is associated with decreased risk of coronary and 
carotid stenosis, peripheral atherosclerosis, ischaemic heart 
disease, vascular complications in diabetics and even can-
cer (Vítek et al. 2002; Hjelkrem et al. 2012).
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RDW has been reported as an inflammatory bio-
marker to be increased in myocardial infarction, heart 
failure, chronic kidney disease and inflammatory status 
in the literature. Furthermore, it has a prognostic value 
in patients with heart failure and coronary artery disease 
(CAD) (Balta et  al. 2013a; Cakar et  al. 2013). NLR has 
been shown to be associated with prognosis of malignan-
cies and cardiovascular diseases (Balta et al. 2013b). NLR 
is rapid and simple parameter of systemic inflammation 
and related to the severity of CAD (Zahorec 2001; Arbel 
et  al. 2012). A recently published study demonstrated 
that NLR is an independent predictor of subclinical ath-
erosclerosis in patients with prediabetes (Hamur et  al. 
2016). High NLR and PLR are related to adverse cardiac 
events and extent of atherosclerosis (Cicek et  al. 2015; 
Chia et  al. 2009; Bian et  al. 2010). PLR was introduced 
as a potential marker to determine inflammation in car-
diac and oncologic disorders (Azab et  al. 2012; Kwon 
et  al. 2012). NaveenKumar et  al. (2015) indicated that 
UCB induced apoptosis in platelets in vitro at the con-
centration range 0–200 μM (0–11.7 mg/dL). Some stud-
ies have demonstrated the association between elevated 
blood platelet count and major adverse cardiovascular 
outcomes (Nikolsky et al. 2007; Iijima et al. 2007). Also, 
Nunez et al. stated that low lymphocyte count was asso-
ciated with mortality and cardiovascular diseases (Nunez 
et al. 2011).
In this study, we aimed to investigate the relation 




This study was approved by the Local Ethics Commit-
tee of Gulhane Military Medical Faculty and designed as 
a cross-sectional and retrospective study. 2166 subjects 
were selected among 33,695 people who had applied for 
a bill of health to our hospital between October 2011 
and December 2014 for application of a new job or who 
wish to continue the existing duty with any known com-
plaint or detected disease (evaluated by the specialists of 
internal medicine, general surgery, cardiology, urology, 
ear-nose and throat, eye, orthopedics, neurology, derma-
tology and psychiatry). Their data were collected from 
the Military Health Management System (a database 
used in our hospital). 1082 individuals with the diagno-
sis of GS and 1084 healthy controls were included in the 
study. The control group was selected randomly among 
the people whose all laboratory values were within nor-
mal references. All of the GS subjects and controls were 
males. The viral hepatitis markers, recent drug use his-
tory for liver injury were negative and blood pressures 
were normal in all subjects.
The criteria for the GS diagnosis were: fasting uncon-
jugated bilirubin >1  mg/dL, normal liver function tests, 
lack of diseases that may cause bilirubin elevation and 
a normal abdominal ultrasonography (Sieg et  al. 1987). 
The blood samples were collected after an overnight fast. 
The elevation in UCB at least two different analyses was 
accepted as GS. Smokers, subjects having a disease that 
may cause bilirubin elevation and cases having stone in 
gallbladder or biliary tract were excluded from the study. 
Due to the small size of the group of individuals over 
35 years old, and because they have affected the normal 
distribution they were excluded from the study. In all 
subjects age, complete blood count, conjugated biliru-
bin, unconjugated bilirubin, total bilirubin, alanine ami-
notransferase (ALT), aspartate aminotransferase (AST), 
urea, creatinine and fasting plasma glucose levels were 
recorded.
Statistical analysis
For statistical analysis, SPSS (Statistical Package for the 
Social Sciences ver. 15.0, SPSS Inc, Chicago, Illinois, 
USA) computer program was used. The variables were 
investigated using visual (histograms, probability plots) 
and analytical method Kolmogorov–Smirnov test to 
determine whether or not they are normally distributed. 
The Pearson correlation test was used to assess the cor-
relation between parametric variables, and the Spear-
man test was used for nonparametric variables. For 
comparison of the groups Mann Whitney U/Student’s 
t-test were used, where appropriate. A multiple linear 
regression analysis was used to identify independent 
predictors of UCB. As independent variables age, RDW, 
platelet and lymphocyte counts were entered into the 
analysis. Abnormal distributed data was log-transformed 
for regression analysis. Quantitative variables were 
expressed as mean  ±  standard deviation. All statistical 
tests were 2-tailed and p < 0.05 was considered as statisti-
cally significant.
Results
The characteristics of the study population were sum-
marized in Table  1. There were 1082 subjects with GS 
and 1084 healthy controls. The mean ages of the GS and 
control groups were 22.9  ±  3.6 and 22.8  ±  2.9  years; 
p = 0.114, respectively (Table 1). The total bilirubin and 
UCB measurements of the GS and control groups were 
1.75  ±  0.53 and 0.59  ±  0.21  mg/dL, 1.56  ±  0.52 and 
0.43  ±  0.19  mg/dL; p  <  0.001, respectively (Table  1). 
NLR and PLR levels were higher in the subjects with GS, 
compared to the controls (2.65 ±  1.05, 1.45 ±  0.50 and 
9.95 ±  3.73, 6.80 ±  2.02; p < 0.001, respectively). RDW 
levels were similar in both groups (p = 0.318). RBC lev-
els were higher in the GS group (p < 0.001). Platelet and 
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lymphocyte counts were lower in the subjects with GS 
compared to the controls (240.3  ±  53.3, 258.2  ±  55.5 
and 1.8  ±  0.5, 2.7  ±  0.6; p  <  0.001, respectively). UCB 
was negatively correlated with lymphocyte and platelet 
counts, and positively correlated with RBC, urea, cre-
atinine, NLR, neutrophil counts and PLR in the whole 
group (Table 2). UCB was negatively correlated with lym-
phocyte counts (Pearson’s r  =  −0.109, p  =  0.040), and 
positively correlated with RDW (Spearman r  =  0.166, 
p < 0.001) and PLR (Spearman r = 0.098, p = 0.037) in 
the subjects with GS. There was no significant corre-
lation between UCB levels and NLR (p =  0.078) in the 
GS group. A multiple linear regression analysis was per-
formed by using the independent variables age, RDW, 
platelet and lymphocyte counts. RDW (β  =  0.181, 
p  <  0.001) and lymphocyte counts (β  =  −0.100, 
p = 0.030) were significantly associated with UCB levels 
in the multiple linear regression analysis conducted in 
the subjects with GS, respectively (Figs. 1, 2).
Discussion
RDW, NLR and PLR are the predictors of subclinical ath-
erosclerosis at higher levels. In our study we aimed to 
investigate the relation between these markers and UCB 
levels. Furthermore, we aimed to determine whether 
there is an association between UCB levels with these 
inflammatory markers. In the present study we found 
that UCB was associated with RDW and PLR in GS 
group. There was no association between UCB and NLR. 
In GS group higher NLR and PLR might be due to the 
lower amounts of lymphocytes, compared to neutrophil 
and platelet counts.
In the present study UCB was significantly and posi-
tively associated with RDW levels in regression analy-
sis conducted in the GS group. RDW as a marker of the 
variability in erythrocyte volume is a routinely avail-
able component of the complete blood count (CBC). In 
patients with ineffective red cell production, increased 
red cell destruction and blood transfusion, RDW levels 
can be elevated (Förhécz et al. 2009). RDW reflects vari-
ability in the size of circulating red cells and is routinely 
reported by analyzers as part of routine CBCs. Several 
studies in the literature have reported that elevated RDW 
levels are significantly associated with a poor prognosis 
in the setting of heart failure, acute myocardial infarc-
tion and stable angina pectoris. RDW is recognized as 
a global marker of chronic inflammation and oxidative 
stress (Balta et al. 2013a; Cakar et al. 2013). However, the 
underlying biological mechanisms remain unclear. In our 
Table 1 Baseline characteristics of the study population
UCB unconjugated bilirubin, TB total bilirubin, Hb hemoglobin, RBC red blood 
cell, Plt platelets, RDW red cell distribution width, WBC white blood cell, NLR 
neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio. Independent 
samples t test for normally distributed data. Mann Whitney U test for abnormally 
distributed data. Values are given as mean ± standard deviation
Gilbert (n = 1082) Control (n = 1084) p value
Age (years) 22.9 ± 3.6 22.8 ± 2.9 .114
Creatinine (mg/dL) 0.97 ± 0.15 0.86 ± 0.12 <.001
Urea (mg/dL) 28.5 ± 7.3 27.6 ± 6.0 .158
Fasting glucose 
(mg/dL)
86.6 ± 11.3 85.4 ± 8.4 .040
UCB (mg/dL) 1.56 ± 0.52 0.43 ± 0.19 <.001
TB (mg/dL 1.75 ± 0.53 0.59 ± 0.21 <.001
Hb (g/dL) 15.8 ± 1.2 15.3 ± 1.0 <.001
RBC (K/μL) 5.44 ± 0.44 5.17 ± 0.38 <.001
Plt (K/μL) 240.3 ± 53.3 258.2 ± 55.5 <.001
RDW (%) 12.2 ± 1.6 12.3 ± 0.8 .318
WBC (K/μL) 7.2 ± 2.0 7.0 ± 1.3 .741
Lymphocyte (K/μL) 1.8 ± 0.5 2.7 ± 0.6 <.001
Neutrophil (K/μL) 4.4 ± 1.4 3.8 ± 1.1 <.001
NLR 2.65 ± 1.05 1.45 ± 0.50 <.001
PLR 9.95 ± 3.73 6.80 ± 2.02 <.001
Table 2 Correlations in the whole group
UCB unconjugated bilirubin, RBC red blood cell, NLR neutrophil to lymphocyte 
ratio, PLR platelet to lymphocyte ratio. Pearson correlation analysis for normally 
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study the association between UCB and RDW might only 
be the response of bone marrow to increased red cell 
destruction in the subjects with GS and so RDW does 
not reflect the inflammation.
In our study RBC levels were higher in the subjects 
with GS compared to the healthy controls. Wallner et al. 
showed a positive correlation between unconjugated bili-
rubin and free heme, iron and carboxy hemoglobin which 
might be the result of a positive feedback loop of heme 
oxygenase induction mediated by unconjugated biliru-
bin (Wallner et al. 2013). Similarly, bone marrow can be 
stimulated by high amounts of iron, free heme and car-
boxy hemoglobin which have been released from the 
hemolytic process in the subjects with GS in our study. 
Therefore, because of the activation of bone marrow the 
RBC levels might be higher in the GS group.
Platelet counts were significantly lower in the subjects 
with GS compared to the control group in our study. 
Suvansri et al. (1969) showed that UCB affected platelet 
volume and platelet count in hyperbilirubinemic individ-
uals. NaveenKumar et al. found that UCB induced apop-
totic events in platelets including elevated endogenous 
reactive oxygen species (ROS) generation, mitochondrial 
membrane depolarization, increased intracellular cal-
cium levels, cardiolipin peroxidation and phosphatidyl-
serine externalization. They also indicated that elevated 
UCB caused thrombocytopenia by stimulating platelet 
apoptosis via mitochondrial ROS-induced p38 and p53 
activation (NaveenKumar et  al. 2015). This may be one 
of the main mechanisms which cause a reduction in the 
platelet counts in our study. Moreover, lower platelet 
counts cause lower P-selectin levels, which leads to less 
thrombotic events (Kundur et  al. 2015). P-selectin is an 
adhesion molecule released from granules of activated 
platelets and endothelial cells. It mediates the adhesion of 
platelets and inflammatory cells to the endothelial surface 
(Blann and Lip 1997; McEver 1991). Tapan et  al. (2009) 
showed decreased soluble P-selectin levels in GS. P-selec-
tin can attract inflammatory cells, induce endothelial cell 
activation and platelet aggregation when released from 
activated platelets (Blann and Lip 1997; Lievens et  al. 
2010). Also, P-selectin plays an essential role in thrombus 
formation by facilitating the development of large sta-
ble platelet-leukocyte aggregates (Yokoyama et al. 2005). 
Ridker et al. (2001) demonstrated that healthy individuals 
with elevated concentrations of P-selectin have increased 
risk of suffering a future cardiovascular event. Moreover, 
inhibition of circulating P-selectin is associated with a 
reduced risk of thrombus formation and is evolving as a 
therapeutic target for treatment and prevention of future 
CVD (Chelliah et  al. 2009). These findings suggest that 
GS subjects may have lower risk of thrombosis due to 
an indirect effect of bilirubin reducing P-selectin levels 
which leads to less cardiovascular events.
NLR may act as a marker of inflammation in several 
cardiac and non-cardiac conditions (Balta et  al. 2016). 
Hamur et  al. (2016) demonstrated that higher NLR and 
lower total bilirubin levels were independent predictors 
of subclinical atherosclerosis in patients with prediabe-
tes. They showed a negative correlation between NLR 
and total bilirubin in their study. Conversely there was a 
positive correlation between total bilirubin and NLR in 
our study. However, in their study total and unconjugated 
bilirubin levels were within normal ranges. It would be 
wrong to make an inference with normal values of bili-
rubin. We hypothesize that UCB has a lowering effect 
Fig. 1 The regression analysis conducted in the subjects with GS 
(β = 0.181; p < 0.001). UCB was positively correlated with RDW. (UCB 
was log-transformed for analysis)
Fig. 2 The regression analysis conducted in the subjects with GS 
(β = −0.100, p = 0.030). UCB was negatively correlated with lympho-
cyte counts. (UCB was log-transformed for analysis)
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on lymphocytes in mildly elevated levels. The NLR was 
higher in GS group compared to controls because of the 
low lymphocyte counts in this group. Therefore a positive 
correlation between UCB and NLR was observed in our 
study.
In our study we found significantly lower lymphocyte 
counts in the GS group compared to the control group. 
UCB has been shown to lead to apoptosis of cells through 
an association of UCB with mitochondrial membranes, 
leading to cytochrome C release into the cytosol and acti-
vation of caspase-9 (Keshavan and Schwemberger 2004). 
This condition may be the result of apoptotic effect of 
UCB lowering lymphocyte counts (Jangi et al. 2013).
Study limitations
This study aims to use the advantage of a huge number 
of GS subjects on complete blood cell count param-
eters. But as a retrospective and cross-sectional study, 
our study lacks the benefit of long time prospective case 
control studies. Our findings are inherently limited in 
the ability to eliminate the causal relationships between 
RDW, NLR, PLR and bilirubin. Higher ratios of NLR and 
PLR are due to low lymphocyte counts in the GS group in 
our study. Therefore, the interpretation of NLR and PLR 
are difficult, because lymphocyte counts are decreased. 
Additional markers of neutrophil and platelet activation 
are required (i.e. P-selectin, L-selectin) to determine the 
significance of these findings. Further prospective popu-
lation based studies are needed to investigate the mecha-
nisms in order to answer these questions. Determining 
the levels of inflammatory markers in serum samples of 
GS subjects in terms of endothelial dysfunction or meas-
uring the flow mediated dilation or arterial stiffness of 
these subjects would give information beyond using only 
complete blood count parameters, but these measure-
ments were not practical for so many people. Lack of 
lipid profile, uric acid levels, other inflammatory mark-
ers such as high sensitive C-reactive protein and BMIs 
restricted our comments about inflammatory properties 
of UCB in the subjects. Other limitations are that only 
males and under the age of 35 years were included in this 
study. Complete blood cell parameters may be affected 
by some factors such as the waiting time of blood sam-
ple in tubes before laboratory study or an unannounced 
inflammatory condition. This may have caused some dis-
turbances in our results.
Conclusion
In this study we found that there was a reduction in 
platelet counts in mildly elevated (1–4  mg/dL) serum 
levels of UCB. The ongoing apoptotic effect of UCB on 
platelets has been shown in other studies at higher levels 
to 11.7  mg/dL. We believe that, UCB has a protective 
effect on CVD indirectly by affecting the pro-inflamma-
tory processes. However, we saw that there is a nega-
tive association between UCB and NLR, PLR due to low 
amounts of lymphocyte counts, which causes increased 
risk of CVD. These results suggest that the cardio-protec-
tive effect of UCB is due to both anti-oxidative and anti-
inflammatory ways indirectly.
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